Nyxoah SA Ordinary Shares NYXH 深 滬
已收盤 10-24 16:00:00 美东时间
5.61
-0.060
-1.06%
華盛通- 最 高5.695
- 今 開5.69
- 成交量 2.25万股
- 最 低 5.43
- 昨 收 5.67
- 總市值 2.10亿
- 52周最高 11.87
- 市盈率 靜 --
- 換手率 0.06%
- 52周最低 4.345
- 委 比 8.86%
- 總股本 3744.11万
- 歷史最高 37.00
- 量 比 0.67
- 振 幅 4.67%
- 歷史最低 4.00
- 每 手 1
- 風險率 1.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Inspire Medical cut at Jefferies on GLP-1 uptake, potential rivalry
Shares of Inspire Medical Systems (NYSE:INSP) slipped on Friday after Jefferies downgraded the MedTech player to Hold from Buy, citing multiple headwinds for the company, including potential competiti...
10-25 00:39
First US Patients Implanted With Nyxoah's CE-Marked Genio System Signal Strong Demand For Breakthrough Sleep Apnea Therapy
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio SystemEarly Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorizations, and Widespread Payor Coverage
10-06 13:59
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
Nyxoah announced the first U.S. commercial patients implanted with its Genio® system following FDA approval, marking a significant milestone in treating Obstructive Sleep Apnea (OSA). CEO Olivier Taelman highlighted strong physician demand, successful pre-authorization, and widespread payer coverage. Dr. Andrew T. Huang, the first surgeon to implant Genio commercially in the U.S., praised the system's effectiveness and ease of use. Nyxoah is trac...
10-06 05:00
Nyxoah Enters Underwriting Agreement for Public Offering
The latest announcement is out from Nyxoah ( ($NYXH) ). On September 18, 2025, ...
09-24 04:58
Nyxoah Announces Continued Expansion Of Commercial Footprint In Middle East, Following First Genio Implant In Abu Dhabi In September 2025
Nyxoah Provides an Update on Expanded Middle East PresenceNew Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025Mont-Saint-Guibert, Belgium – September 23, 2025,
09-24 04:12
Nyxoah Provides an Update on Expanded Middle East Presence
Nyxoah expands its Middle East presence with new centers in Dubai, Kuwait, and Abu Dhabi, following the first successful Genio® implant in the region in September 2025. The company aims to increase access to its patient-centric treatment for Obstructive Sleep Apnea (OSA) and improve patient outcomes.
09-23 20:10
Kepler Capital Remains a Buy on Nyxoah (NYXH)
In a report released on September 16, Christophe dombu from Kepler Capital main...
09-18 09:45
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems Over Sleep Apnea Device Technology
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah,
09-16 04:11
Nyxoah Announces Change in Voting Rights Stake by Cochlear
Nyxoah ( ($NYXH) ) just unveiled an announcement. On September 5, 2025, Nyxoah ...
09-09 04:27
Nyxoah Announces Transparency Notification on Shareholding Changes
The latest update is out from Nyxoah ( ($NYXH) ). Nyxoah SA has announced a tra...
09-06 10:02
